A single-center, randomized, parallel controlled study comparing the efficacy and safety aspects of three anthracycline-based regimens as neoadjuvant chemotherapy in primary breast cancer
Crossref DOI link: https://doi.org/10.1007/s10549-016-3843-7
Published Online: 2016-06-01
Published Print: 2016-06
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Zhou, Yijun
Ouyang, Tao
Xie, Yuntao
Wang, Tianfeng
Fan, Zhaoqing
He, Yingjian
Lu, Aiping
Liu, Yiqiang
Li, Jinfeng
License valid from 2016-06-01